tryptamine has been researched along with Movement Disorders in 1 studies
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Harmalan induced clonic convulsions which were antagonized by diazepam." | 1.27 | Pharmacology of harmalan (1-methyl-3,4-dihydro-beta-carboline). ( Brüning, G; Hill, R; Nick, M; Rommelspacher, H; Susilo, R, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rommelspacher, H | 1 |
| Brüning, G | 1 |
| Susilo, R | 1 |
| Nick, M | 1 |
| Hill, R | 1 |
1 other study available for tryptamine and Movement Disorders
| Article | Year |
|---|---|
Pharmacology of harmalan (1-methyl-3,4-dihydro-beta-carboline).
Topics: Animals; Behavior, Animal; Binding Sites; Carbolines; Cerebral Cortex; Convulsants; Female; Hydroxyi | 1985 |